In a report published today by the World Health Organization (WHO), officials outlined their recommendations for the composition of the influenza vaccine for the 2017-2018 northern hemisphere flu season....

The high-dose flu vaccine appeared to be more effective at preventing post-influenza deaths among older adults than the standard-dose vaccine, at least during a more severe flu season, according to a large...

In an effort to rapidly contain the resurgence of cholera in South Sudan, WHO has secured oral cholera vaccine to vaccinate the communities in Leer Town and other areas. The 20 February integrated food...

A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda,...

A nationwide polio immunization campaign was launched this week in Yemen by national health authorities with support from WHO and UNICEF, aiming to immunize 5,019,648 children under the age of 5. More...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide...

Microsoft founder Bill Gates and Gates Foundation philanthropist offered some thoughts and a dire warning Saturday during a panel discussion, “Health Security: Small Bugs, Big Bombs” at the...

100,000, or one lakh of children in India dies each year from the gastrointestinal virus, rotavirus. Today, Union Minister for Health and Family Welfare,  Shri J P Nadda announced the expansion of...

Vaccine developers have successfully protected mice against Zika by injecting synthetic messenger RNA that encodes for virus proteins into the animals. The cells of the mice then build parts of the virus,...

In a report published Wednesday in Nature, (Sterile protection against human malaria by chemoattenuated PfSPZ vaccine) investigators from the University of Tübingen reported all nine subjects (100%)...